These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8324212)

  • 1. Effect of pyrazinamide on rifampicin kinetics in patients with tuberculosis.
    Jain A; Mehta VL; Kulshrestha S
    Tuber Lung Dis; 1993 Apr; 74(2):87-90. PubMed ID: 8324212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum concentrations of rifampicin and isoniazid in tuberculosis.
    Seth V; Beotra A; Seth SD; Semwal OP; Kabra S; Jain Y; Mukhopadhya S
    Indian Pediatr; 1993 Sep; 30(9):1091-8. PubMed ID: 8125594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clearance of theophylline is increased during the initial period of tuberculosis treatment.
    Ahn HC; Lee YC
    Int J Tuberc Lung Dis; 2003 Jun; 7(6):587-91. PubMed ID: 12797703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative bioavailability of rifampicin, isoniazid and pyrazinamide from a four drug fixed dose combination with separate formulations at the same dose levels.
    Agrawal S; Singh I; Kaur KJ; Bhade SR; Kaul CL; Panchagnula R
    Int J Pharm; 2004 May; 276(1-2):41-9. PubMed ID: 15113612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The disposition of antituberculous drugs in plasma of elderly patients. II. Isoniazid, rifampicin and pyrazinamide.
    Walubo A; Chan K; Woo J; Chan HS; Wong CL
    Methods Find Exp Clin Pharmacol; 1991 Oct; 13(8):551-6. PubMed ID: 1956210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of simultaneous isoniazid administration on pharmacokinetic parameters of pyrazinamide.
    Singhal KC; Varshney MK
    J Indian Med Assoc; 1991 Aug; 89(8):227-9. PubMed ID: 1748799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic interaction between rifampicin and the once-daily combination of saquinavir and low-dose ritonavir in HIV-infected patients with tuberculosis.
    Ribera E; Azuaje C; Lopez RM; Domingo P; Curran A; Feijoo M; Pou L; Sánchez P; Sambeat MA; Colomer J; Lopez-Colomes JL; Crespo M; Falcó V; Ocaña I; Pahissa A
    J Antimicrob Chemother; 2007 Apr; 59(4):690-7. PubMed ID: 17307771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Short-term therapy of lung tuberculosis using a fixed combination of isoniazid, rifampicin and pyrazinamide. Results after 2 years].
    Brändli O; Haegi V; Villiger B; Bohn W; Baumann HR; Zäch R
    Schweiz Med Wochenschr; 1989 Mar; 119(10):299-305. PubMed ID: 2652281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of rifampicin and pyrazinamide on isoniazid pharmacokinetics in rats.
    Baldan HM; De Rosa HJ; Brunetti IL; Ximenes VF; Machado RG
    Biopharm Drug Dispos; 2007 Nov; 28(8):409-13. PubMed ID: 17828712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
    Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
    East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioequivalence assessment of rifampicin, isoniazid and pyrazinamide in a fixed dose combination of rifampicin, isoniazid, pyrazinamide and ethambutol vs. separate formulations.
    Agrawal S; Singh I; Kaur KJ; Bhade SR; Kaul CL; Panchagnula R
    Int J Clin Pharmacol Ther; 2002 Oct; 40(10):474-81. PubMed ID: 12395981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modified short-course chemotherapy of pulmonary tuberculosis in Ibadan, Nigeria--a preliminary report.
    Ige OM; Bakare NA; Onadeko BO
    Afr J Med Med Sci; 2000 Mar; 29(1):51-3. PubMed ID: 11379469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM; Goldberg SV
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Six-month short course chemotherapy containing pyrazinamide for initial treatment of pulmonary tuberculosis].
    Wada M; Yosiyama T; Yosikawa M; Ogata H; Sugie T; Nakasono T; Sugita H
    Kekkaku; 1994 Nov; 69(11):671-80. PubMed ID: 7837720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic effect of rifampicin on re-treatment cases of pulmonary tuberculosis. The second study: a study on the combined therapy of rifampicin with ethambutol and pyrazinamide, especially on intermittent therapy].
    Kekkaku; 1972 Dec; 47(12):457-66. PubMed ID: 4652424
    [No Abstract]   [Full Text] [Related]  

  • 17. [Combined chemotherapy of patients with tuberculosis - new regimens and dosage forms].
    Sokolova GB; Koriakin VA; Khalbaeva IV; Elistratova NA; Ziia AV
    Probl Tuberk; 1993; (5):21-3. PubMed ID: 8295879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacteriological investigations for short-course chemotherapy under the tuberculosis programme in two districts of India.
    Paramasivan CN; Chandrasekaran V; Santha T; Sudarsanam NM; Prabhakar R
    Tuber Lung Dis; 1993 Feb; 74(1):23-7. PubMed ID: 8495016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacokinetic aspects of tuberculosis therapy with a fixed combination of rifampicin, isoniazide and pyrazinamide].
    Schaberg T; Lode H
    Z Gesamte Inn Med; 1991 Jun; 46(8):276-9. PubMed ID: 1897286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The disposition of antituberculous drugs in plasma of elderly patients. I. Isoniazid and hydrazine metabolite.
    Walubo A; Chan K; Woo J; Chan HS; Wong CL
    Methods Find Exp Clin Pharmacol; 1991 Oct; 13(8):545-50. PubMed ID: 1956209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.